Unity Biotechnology, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Unity Biotechnology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Unity Biotechnology, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 16.8M shares, a 15.4% increase year-over-year.
  • Unity Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 14.8M shares, a 55.6% increase from 2022.
  • Unity Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 9.49M shares, a 70.1% increase from 2021.
  • Unity Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 5.58M shares, a 9.73% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 16.8M +2.25M +15.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 16.8M +2.39M +16.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 16.8M +2.47M +17.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 14.8M +5.28M +55.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 14.6M +4.53M +44.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 14.4M +7.5M +108% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 14.3M +7.56M +112% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 9.49M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 10.1M +4.53M +81.7% Jul 1, 2022 Sep 30, 2022 10-K 2024-04-15
Q2 2022 6.92M -47.9M -87.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 6.75M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 5.54M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 54.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.